Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 290 | 3 | COENZYME Q10//VITAMIN E//TOCOTRIENOL | 42758 |
| 1412 | 2 | ISOPROSTANES//ISCHEMIA MODIFIED ALBUMIN//OXIDATIVE STRESS | 8232 |
| 9617 | 1 | ISOPROSTANES//F 2 ISOPROSTANES//NEUROPROSTANES | 1169 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ISOPROSTANES | authKW | 3599735 | 26% | 43% | 309 |
| 2 | F 2 ISOPROSTANES | authKW | 742831 | 8% | 31% | 88 |
| 3 | NEUROPROSTANES | authKW | 685052 | 3% | 71% | 36 |
| 4 | PHYTOPROSTANES | authKW | 460028 | 2% | 74% | 23 |
| 5 | 8 ISO PROSTAGLANDIN F 2 ALPHA | authKW | 385328 | 2% | 53% | 27 |
| 6 | 8 ISO PGF2 ALPHA | authKW | 300853 | 2% | 45% | 25 |
| 7 | CLAUDE PEPPER | address | 299530 | 3% | 34% | 33 |
| 8 | 8 EPI PGF2 ALPHA | authKW | 255597 | 1% | 59% | 16 |
| 9 | UMR 5074 | address | 209149 | 1% | 52% | 15 |
| 10 | 8 EPI PROSTAGLANDIN F 2 ALPHA | authKW | 194094 | 1% | 60% | 12 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Biochemistry & Molecular Biology | 1694 | 34% | 0% | 393 |
| 2 | Endocrinology & Metabolism | 1466 | 15% | 0% | 170 |
| 3 | Nutrition & Dietetics | 370 | 5% | 0% | 62 |
| 4 | Peripheral Vascular Diseases | 287 | 5% | 0% | 62 |
| 5 | Cell Biology | 267 | 10% | 0% | 113 |
| 6 | Chemistry, Organic | 222 | 8% | 0% | 91 |
| 7 | Biochemical Research Methods | 219 | 5% | 0% | 64 |
| 8 | Pharmacology & Pharmacy | 166 | 9% | 0% | 111 |
| 9 | Cardiac & Cardiovascular System | 144 | 6% | 0% | 66 |
| 10 | Medical Laboratory Technology | 139 | 2% | 0% | 24 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CLAUDE PEPPER | 299530 | 3% | 34% | 33 |
| 2 | UMR 5074 | 209149 | 1% | 52% | 15 |
| 3 | EXCELLENCE INFLAMMAT | 188698 | 1% | 50% | 14 |
| 4 | UMR CNRS 5074 | 110076 | 1% | 58% | 7 |
| 5 | PHARMIBMMUMR 5247 | 86267 | 0% | 80% | 4 |
| 6 | CHIM BIOMOL INTERACT BIOL | 80871 | 1% | 50% | 6 |
| 7 | CLIN PHARMACOL THER EUT TOXICOL | 74881 | 0% | 56% | 5 |
| 8 | SECT GERIATR CLIN NUTR | 74649 | 1% | 46% | 6 |
| 9 | SECT CLIN NUTR | 69388 | 1% | 23% | 11 |
| 10 | FI TONE P HLTHASTHMA GRP | 60656 | 0% | 75% | 3 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | FREE RADICAL BIOLOGY AND MEDICINE | 10900 | 5% | 1% | 60 |
| 2 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 9842 | 3% | 1% | 34 |
| 3 | FREE RADICAL RESEARCH | 9688 | 3% | 1% | 33 |
| 4 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 5639 | 2% | 1% | 20 |
| 5 | ANTIOXIDANTS & REDOX SIGNALING | 4469 | 2% | 1% | 23 |
| 6 | SKIN PHARMACOLOGY & PHYSIOLOGY | 3850 | 0% | 14% | 1 |
| 7 | CHEMISTRY AND PHYSICS OF LIPIDS | 2086 | 1% | 0% | 16 |
| 8 | REDOX REPORT | 1374 | 1% | 1% | 7 |
| 9 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 1214 | 1% | 1% | 6 |
| 10 | JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 1120 | 2% | 0% | 23 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ISOPROSTANES | 3599735 | 26% | 43% | 309 | Search ISOPROSTANES | Search ISOPROSTANES |
| 2 | F 2 ISOPROSTANES | 742831 | 8% | 31% | 88 | Search F+2+ISOPROSTANES | Search F+2+ISOPROSTANES |
| 3 | NEUROPROSTANES | 685052 | 3% | 71% | 36 | Search NEUROPROSTANES | Search NEUROPROSTANES |
| 4 | PHYTOPROSTANES | 460028 | 2% | 74% | 23 | Search PHYTOPROSTANES | Search PHYTOPROSTANES |
| 5 | 8 ISO PROSTAGLANDIN F 2 ALPHA | 385328 | 2% | 53% | 27 | Search 8+ISO+PROSTAGLANDIN+F+2+ALPHA | Search 8+ISO+PROSTAGLANDIN+F+2+ALPHA |
| 6 | 8 ISO PGF2 ALPHA | 300853 | 2% | 45% | 25 | Search 8+ISO+PGF2+ALPHA | Search 8+ISO+PGF2+ALPHA |
| 7 | 8 EPI PGF2 ALPHA | 255597 | 1% | 59% | 16 | Search 8+EPI+PGF2+ALPHA | Search 8+EPI+PGF2+ALPHA |
| 8 | 8 EPI PROSTAGLANDIN F 2 ALPHA | 194094 | 1% | 60% | 12 | Search 8+EPI+PROSTAGLANDIN+F+2+ALPHA | Search 8+EPI+PROSTAGLANDIN+F+2+ALPHA |
| 9 | IPF2 ALPHA III | 188712 | 1% | 100% | 7 | Search IPF2+ALPHA+III | Search IPF2+ALPHA+III |
| 10 | DIHOMO ISOPROSTANES | 165121 | 1% | 88% | 7 | Search DIHOMO+ISOPROSTANES | Search DIHOMO+ISOPROSTANES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |